Results for tag: CLL Total Items Found: 29

Jeff Sharman on Acalabrutinib, Obinutuzumab, and Chlorambucil for CLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
acalabrutinib
ash annual meeting
chlorambucil
cll
elevate tn
leukemia
obinutuzumab
pfs
acalabrutinib
ash annual meeting
chlorambucil
cll
elevate tn
leukemia
obinutuzumab
pfs

Created: 12/11/2019 9:27:03 PM

Jennifer Crombie on Duvelisib and Venetoclax for Relapsed or Refractory CLL/SLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
ash annual meeting
cll
duvelisib
leukemia
lymphoma
refractory
relapsed
sll
venetoclax

Created: 12/11/2019 7:35:59 PM

Tait Shanafelt on Comparing Ibrutinib and Rituximab With FCR in Younger Patients With CLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
ash annual meeting
cll
chronic lymphocytic leukemia
ibrutinib
rituximab
FCR

Created: 12/9/2019 3:19:51 AM

Nitin Jain on First-Line Ibrutinib Plus Venetoclax in CLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
cll
chronic lymphocytic leukemia
ibrutinib
oral regimen
venetoclax

Created: 12/8/2019 6:37:33 PM

Nitin Jain on the Role for Chemoimmunotherapy for CLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
cll
chemoimmunotherapy
chronic lymphocytic leukemia
first-line therapy
leukemia
NCCN Hematologic Malignancies

Created: 10/8/2019 8:10:16 PM

William Wierda on Evolving Strategies for First-Line Treatment of CLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
cll
nccn
bcl2 inhibitor
bruton's tyrosine kinase
BTK inhibitors
btk
chemoimmunotherapy
leukemia
NCCN Hematologic Malignancies

Created: 10/8/2019 7:46:55 PM

Kerry A. Rogers, MD, on Acalabrutinib With Obinutuzumab in CLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
acalabrutinib
asco 2019
chronic lymphocytic leukemia
cll
obinutuzumab
Caroline Helwick
asco 2019
chronic lymphocytic leukemia
CLL
obinutuzumab

Created: 6/4/2019 5:57:51 PM

William Wierda on TRANSCEND CLL 004

Type of Page:TapVideo
Edit This Item
Tags for this item:
cll
asco 2019
CAR T-cell
F. Owen Hoffman
immunotherapy
Caroline Helwick
transcend cll 004

Created: 6/4/2019 5:52:31 PM

Tait Shanafelt on CLL Results From a Trial of the ECOG-ACRIN Cancer Research Group

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2018
CLL
chronic lymphocytic leukemia
ibrutinib
fludarabine
cyclophosphamide
rituximab

Created: 12/4/2018 9:52:12 PM

Julie Vose and Merav Bar on Late Effects of CD19-Targeted Treatment

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2018
CAR T cell therapy
CD-19
non-Hodgkin lymphoma
leukemia
chronic lymphocytic leukemia
CLL

Created: 12/3/2018 9:24:24 PM

Jennifer Woyach on CLL Results From the Alliance North American Intergroup Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2018
CLL
chronic lymphocytic leukemia
older patients
ibrutinib
rituximab
bendamustine

Created: 12/2/2018 8:16:10 PM

Susan OBrien on Sequencing Therapy Options in CLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
Pan Pacific Lymphoma
CLL
SLL
chronic lymphocytic leukemia
small lymphocytic lymphoma
chemotherapy
sequencing therapy

Created: 7/24/2018 8:58:01 PM

Peter Hillmen on CLL the MURANO Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
CLL
chronic lymphocytic leukemia
MURANO
venetoclax
rituximab
relapsed
refractory

Created: 6/4/2018 2:16:28 AM

William Wierda and Julie Vose on CLL Results From the CAPTIVATE Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
CLL
chronic lymphocytic leukemia
CAPTIVATE trial
ibrutinib
venetoclax

Created: 6/3/2018 8:05:09 PM

John F. Seymour, MBBS, PhD, on CLL: Results From the MURANO Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
CLL
chronic lymphocytic leukemia
leukemia
MURANO trial
venetoclax
rituximab
bendamustine
relapsed disease
refractory disease
ASH 2017

Created: 12/12/2017 4:43:01 PM

Nitin Jain, MD, on CLL: Results From a Venetoclax/Ibrutinib Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
CLL
chronic lymphocytic leukemia
leukemia
venetoclax
ibrutinib
high-risk disease
relapsed
refractory

Created: 12/10/2017 2:55:49 PM

William G. Wierda, MD, PhD, on CLL: How to Sequence Therapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN Hematologic Malignancies
William Wierda
MD Anderson Cancer Center
CLL
leukemia
chronic lymphocytic leukemia
sequencing therapy
SLL
small lymphocytic leukemia

Created: 10/11/2017 12:01:05 PM

Andrew D. Zelenetz, MD, on CLL: Emerging Treatments

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2016
Memorial Sloan Kettering
Andrew Zelenetz
CLL
chronic lymphocytic leukemia
Gilead 115

Created: 12/4/2016 5:51:46 PM

Jose F. Leis, MD, PhD, and Sagar Lonial, MD, on CLL: Ibrutinib Insights

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2016
Jose Leis
Mayo Clinic
Sagar Lonial
Emory University
CLL
chronic lymphocytic leukemia
ibrutinib
ibrutinib resistance
cellular therapy

Created: 12/4/2016 5:17:31 PM

Sagar Lonial, MD, and Andrew Zelenetz, MD, PhD, on MCL, DLBCL, CLL: How Much Rituximab is Enough?

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2016
Sagar Lonial
Andrew Zelenetz
Memorial Sloan Kettering
Emory University School of Medic
maintenance therapy
rituximab
mantle cell lymphoma
MCL
chronic lymphocytic leukemia
CLL
bendamustine
StiL trial
R-CHOP
diffuse large B-cell lymphoma
DLBCL
HOVON-Nordic Lymphoma Group
French FILO Group

Created: 6/10/2016 9:47:31 AM

Jeffrey Jones, MD, MPH, on Chronic Lymphocytic Leukemia: Optimizing Treatment With New Agents

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 NCCN Annual Meeting
Jeffrey Jones
Ohio State University
James Cancer Hospital
OSUCCC
CLL
chronic lymphocytic leukemia
small molecule inhibitors
personalized treatment

Created: 4/4/2016 2:21:10 PM

Andrew Zelenetz MD PhD on Emerging Treatment Options for Lymphomas

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN
Zelenetz
obinutuzumab
ibrutinib
rituximab follicular lymphoma
DLBCL
CLL
mantle cell

Created: 1/31/2016 9:16:34 AM

William Wierda MD on Updates to CLL Management

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN
William Wierda
CLL
M D Anderson
ibrutinib
idelalisib

Created: 1/31/2016 9:13:53 AM

James O. Armitage, MD, and Asher Chanan-Khan, MD, on Ibrutinib, Bendamustine, and Rituximab in Previously Treated CLL SLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
Mayo Clinic
James Armitage
ASCO
ibrutinib
bendustamine
rituximab
CLL
chronic lymphocytic leukemia
SLL
small lymphocytic lymphoma
University of Nebraska Medical
ASCO 2015
Asher Chanan-Khan

Created: 1/31/2016 9:03:03 AM

Asher Chanan-Khan, MD, Summarizes Ibrutinib, Bendamustine, and Rituximab in Previously Treated CLL/SLL

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO
Chanan-Khan
ibrutinib
bendamustine
rituximab
CLL
SLL
Mayo Clinic
ASCO 2015

Created: 1/31/2016 8:46:46 AM

Sagar Lonial, MD, and Alessandra Tedeschi, MD, on CLL/SLL: Results From the RESONATE-2 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Sagar Lonial
Emory University School of Medic
Alessandra Tedeschi
Azienda Ospedaliera Niguarda Cà
CLL
SLL
chronic lymphocytic leukemia
small lymphocytic leukemia
RESONATE-2 trial
ibrutinib
chlorambucil
older patients
treatment-naïve

Created: 12/24/2015 12:24:03 PM

Andrew D. Zelenetz, MD, PhD, and Stephan Stilgenbauer, MD, PhD on CLL and Venetoclax: Clinical Trial Results

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Andrew Zelenetz
Memorial Sloan Kettering
Stephan Stilgenbauer
University of Ulm
venetoclax monotherapy
deep remission
ultra-high risk relapsed/refract
CLL
17p deletion

Created: 12/24/2015 12:08:43 PM

Andrew D. Zelenetz, MD, PhD, on CLL: Idelalisib Plus Bendamustine and Rituximab

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Andrew Zelenetz
Memorial Sloan Kettering
idelalisib
bendamustine
rituximab
CLL
chronic lymphocytic leukemia
relapsed
refractory

Created: 12/24/2015 12:05:59 PM

Julie Vose, MD, MBA, and Cameron J. Turtle, MBBS, PhD, on B-Cell NHL and CLL: Clinical Trial Results on T-Cell Therapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Julie Vose
University of Nebraska Medical C
Cameron Turtle
Fred Hutch Cancer Center
anti-CD19
B-cell non-Hodgkin lymphoma
NHL
CLL
chronic lymphocytic leukemia
T-cell therapy
chimeric antigen receptor

Created: 12/24/2015 12:02:28 PM
Order By Item Count
Order Alphabetically